none 10.6061/clinics/2015(02)05 Elsevier BV Elsevier 78 74315963 45578 2025102811192900000 10.1016 2025-10-29T06:53:13Z 2015-03-16T15:12:13Z 33 Clinics Clinics 18075932 02 2015 70 2 Oktay Bilgir Ferda Bilgir Mehmet Calan Ozlem Gursoy Calan Arif Yuksel 02 2015 97 101 S1807593222008018 S1807593222008018 10.1016/elsevier_cm_policy elsevier.com sciencedirect.com true Elsevier Comparison of pre- and post-levothyroxine high-sensitivity c-reactive protein and fetuin-a levels in subclinical hypothyroidism Clinics https://doi.org/10.6061/clinics/2015(02)05 article Copyright © 2015 CLINICS. Published by Elsevier Spain https://www.elsevier.com/tdm/userlicense/1.0/ https://www.elsevier.com/legal/tdmrep-license https://creativecommons.org/licenses/by-nc/3.0/ 10.6061/clinics/2015(02)05 https://linkinghub.elsevier.com/retrieve/pii/S1807593222008018 http://clinics.org.br/uploads/artigos/cln-70-02/cln-70-02-097.pdf https://api.elsevier.com/content/article/PII:S1807593222008018?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S1807593222008018?httpAccept=text/plain https://dul.usage.elsevier.com/doi/ http://www.scielo.br/scielo.php?script=sci_abstract&pid=S1807-59322015000200097&lng=en&nrm=iso http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351305/?report=classic Microsomal antibodies as discriminant for therapy. JAMA Rosenthal 258 2 209 1987 Thyroid failure in the elderly Clin Endocrinol (Oxf) Tunbridge 7 6 481 1977 10.1111/j.1365-2265.1977.tb01340.x The spectrum of thyroid disease in a community: the Whickham survey Arch Intern Med Ladenson 160 11 1573 2000 10.1001/archinte.160.11.1573 American Thyroid Association guidelines for detection of thyroid dysfunction J Clin Endocrinol Metab McDermott 86 10 4585 2001 10.1210/jcem.86.10.7959 Subclinical hypothyroidism is mild thyroid failure and should be treated Arch Intern Med Canaris 160 4 526 2000 10.1001/archinte.160.4.526 The Colorado thyroid disease prevalence study J Clin Endocrinol Metab Monzani 82 10 3315 1997 10.1210/jcem.82.10.4296 Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism Clin Endocrinol (Oxf) Monzani 51 2 237 1999 10.1046/j.1365-2265.1999.00790.x Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy Thyroid Misiunas 5 4 283 1995 10.1089/thy.1995.5.283 Peripheral neuropathy in subclinical hypothyroidism Thyroid Beyer 8 11 1029 1998 10.1089/thy.1998.8.1029 Serum creatine kinase levels in overt and subclinical hypothyroidism Thyroid Kahaly 10 8 665 2000 10.1089/10507250050137743 Cardiovascular and atherogenic aspects of subclinical hypothyroidism Thyroid Arem 6 5 397 1996 10.1089/thy.1996.6.397 Cardiac systolic and diastolic function at rest and exercise in subclinical hypothyroidism: effect of thyroid hormone therapy Clin Endocrinol (Oxf) Bell 22 1 83 1985 10.1111/j.1365-2265.1985.tb01068.x End-organ responses to thyroxine therapy in subclinical hypothyroidism J Clin Endocrinol Metab Monzani 86 3 1110 2001 10.1210/jcem.86.3.7291 Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study Circulation Ridker 103 13 1813 2001 10.1161/01.CIR.103.13.1813 High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease Clin Sci (Lond) Kahraman 125 8 391 2013 10.1042/CS20120542 Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients Circulation Ix 113 14 1760 2006 10.1161/CIRCULATIONAHA.105.588723 Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study Diabetes Care Mori 29 2 468 2006 10.2337/diacare.29.02.06.dc05-1484 Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects Diabetes Stefan 57 10 2762 2008 10.2337/db08-0538 Plasma fetuin-A levels and the risk of type 2 diabetes Endocrine Bilgir 45 2 244 2014 10.1007/s12020-013-9993-z Comparison of high-sensitivity C-reactive protein and fetuin-A levels before and after treatment for subjects with subclinical hyperthyroidism Curr Probl Cardiol Bassuk 29 8 439 2004 High-sensitivity C-reactive protein: clinical importance Circulation Ridker 109 16 1955 2004 10.1161/01.CIR.0000125690.80303.A8 Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores J Intern Med Blake 252 4 283 2002 10.1046/j.1365-2796.2002.01019.x Inflammatory bio-markers and cardiovascular risk prediction Circulation Fichtlscherer 102 9 1000 2000 10.1161/01.CIR.102.9.1000 Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease Int Heart J Kokturk 46 5 801 2005 10.1536/ihj.46.801 Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome Circulation Ridker 97 5 425 1998 10.1161/01.CIR.97.5.425 Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease Circulation Koenig 99 2 237 1999 10.1161/01.CIR.99.2.237 C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 J Biol Chem Jahnen-Dechent 272 50 31496 1997 10.1074/jbc.272.50.31496 Cloning and targeted deletion of the mouse fetuin gene J Biol Chem Szweras 277 22 19991 2002 10.1074/jbc.M112234200 alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling Lancet Ketteler 361 9360 827 2003 10.1016/S0140-6736(03)12710-9 Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study Formation of colloidal calciprotein particles. J Biol Chem Heiss 278 15 13333 2003 Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A Clin Sci (Lond) Jersmann 105 3 273 2003 10.1042/CS20030126 Fetuin/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages J Am Soc Nephrol Reynolds 16 10 2920 2005 10.1681/ASN.2004100895 Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification J Ren Nutr Kuźniar 18 1 83 2008 10.1053/j.jrn.2007.10.017 Relationship between fetuin-A concentration, elevated levels of inflammatory markers, and arterial wall stiffness in end-stage kidney disease Clin Endocrinol (Oxf) Mori 66 2 246 2007 10.1111/j.1365-2265.2006.02716.x Association of serum fetuin-A with carotid arterial stiffness